8-K Filing

Company

Eloxx Pharmaceuticals, Inc.

Filed

May 20, 2002

Period of Report

May 17, 2002

Accession Number

0000903100-02-000166

An 8-K is a current report used to announce material events that shareholders should know about — such as earnings releases, mergers, executive changes, or bankruptcy. Learn more about 8-K filings →